Lineage Cell Therapeutics, Inc. Common Stock (NY:LCTX)
1.235
+0.035
(+2.92%)
Streaming Delayed Price
Updated: 9:50 AM EDT, Aug 18, 2025
Add to My Watchlist
Headline News about Lineage Cell Therapeutics, Inc. Common Stock
Lineage Cell Revenue Doubles in Q2
August 12, 2025
Via The Motley Fool
![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|